Friday, January 21, 2022

AstraZeneca Covid-19 vaccine

Covishield production in full swing in Pune, says Poonawalla

India rolled out the third phase of its COVID-19 vaccination drive for those in the age group of 18-45 years on Saturday.

Serum Institute of India refunds South Africa for undelivered COVID-19 vaccines

A million doses from the institute, which had already been delivered, have been sold on to other countries in the African Union.

AstraZeneca, blood clots link ‘plausible but not confirmed’: WHO

According to the WHO's statistics, as of Wednesday, at least 2.6 million people have died of Covid-19 worldwide.

Vaccine hesitancy might pose threat to efforts for ending COVID-19 pandemic

Vaccine hesitant people may have anxiety over safety concerns, or they might belong to a community that historically has mistrusted the medical establishment, according to the study.

AstraZeneca says US trial data shows vaccine 79% effective

Investigators said the vaccine was effective across all ages, including older people — which previous studies in other countries had failed to establish.

It has tremendous potential: WHO on AstraZeneca jab

In a statement on Friday, the WHO said that based on available data the review team found no increased risk of blood clotting conditions in people who received the AstraZeneca-Oxford vaccine.

Sweden is latest country to stop using AstraZeneca vaccine

Germany, France, Italy and Spain were among countries that suspended use of the vaccine on Monday.

Thailand PM Prayuth Chan-ocha gets AstraZeneca jab

Thailand last week was the first country outside Europe to temporarily suspend using the AstraZeneca vaccine.

No evidence of high blood clot risk from vaccine: AstraZeneca

"Safety is of paramount importance and the Company is continually monitoring the safety of its vaccine," the company said in a statement on Sunday.

Latest News

- Advertisement -